| |
|
|
| |
|
|
| |
HUM-MOLGEN
-> Events
-> Meetings and Conferences |
|
|
| |
| |
| |
March 25, 2004 |
|
|
| |
|
|
| |
|
|
|
-, July 12-14, 2004
July 12-14, 2004
Investigate the full practical impact on North American companies conducting clinical trials in Europe by understanding definite Member State requirements that will enable submissions to be accepted under the new EU Directive.
|
|
|
|
|
|
|
|
Organized by:
|
|
IBC Life Sciences |
|
|
Invited Speakers:
|
|
-
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
-
|
|
|
|
|
|
|
|
Registration:
|
|
Online: www.LifeSciencesInfo.com/directive
Phone: (508) 616-5550
Fax: (508) 616-5522
E-mail: reg@ibcusa.com
|
|
|
E-mail:
|
|
reg@ibcusa.com
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp,
Frank S.
Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved.
Liability, Copyright and Imprint. |
|